Medium impact
Pharmacy Program Quarterly Update Changes Effective Jan. 1, 2025 – Part 2
BCBS Texas·Effective Jan 1, 2025
Blue Cross and Blue Shield of Texas is adding 40+ new medications to multiple pharmacy formularies effective January 1, 2025, including biosimilars (adalimumab, infliximab, tocilizumab variants), specialty drugs (FABHALTA for paroxysmal nocturnal hemoglobinuria, LITFULO for alopecia areata), and new formulations (ATORVALIQ, EZALLOR SPRINKLE). This is Part 2 of the quarterly update and does not require member notification. The billing team must verify these drugs are now covered and update any prior authorization rules that may apply.